Steven van Lelyveld

Dr. Steven van Lelyveld

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2024 in Eurosurveillance
Verified
Journal Article
Open access
DBDita C Bolluyt
Dita C Bolluyt
SESjoerd M Euser
Sjoerd M Euser
DSDennis Souverein
Dennis Souverein
ARAnnemarie MC van Rossum
Annemarie MC van Rossum
JKJayant Kalpoe
Jayant Kalpoe
MHMarlies A van Houten
Marlies A van Houten
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.

17 January 2021 in medRxiv
Verified
Preprint
Open access
PDF file
SESjoerd M. Euser
Sjoerd M. Euser
SASem Aronson
Sem Aronson
IMIrene Manders
Irene Manders
SLSteven van Lelyveld
Steven van Lelyveld
BHBjorn Herpers
Bjorn Herpers
DSDennis Souverein
Dennis Souverein
Objective: To describe the SARS-CoV-2 viral load distribution in different patient groups and age categories. Methods: All SARS-CoV-2 RT-PCR results from nasopharyngeal (NP) and oropharyngeal (OP) swabs (first PCR from unique patients only) that were collected between January 1 and December 1, 2020, predominantly in the Public Health Services regions Kennemerland and Hollands Noorden, province of North Holland, the Netherlands were included in this study. Swabs were derived from patients with respiratory symptoms who were presented at the general practitioner (GP), hospital, or hospital health care workers (HCWs) of four regional hospitals, nursing home residents and HCWs of multiple nursing homes, and in majority (>75%) from Public Health testing facilities of the two Public Health Services. SARS-CoV-2 PCR crossing point (Cp) values were used to estimate viral loads (higher Cp-values indicate lower viral loads). Results: In total, 278.455 unique patients were tested of whom 9·1% (n=25.374) were SARS-CoV-2 positive. As there were differences in viral load distribution between tested populations, further analyses focused on PCRs performed by public health services (n=211.914) where sampling and inclusion were uniform. These data reveal a clear relation between age and SARS-CoV-2 viral load, with especially children aged<12 years showing lower viral loads than shown in adults (β: −0·03, 95CI% −0·03 to −0·02, p79 years) and youngest (<12 years) population differed by over 4 PCR cycles, suggesting approximately a 16-fold difference in viral load. In addition, the proportion of children aged 30) was significantly higher compared to the other patients (31·1% vs. 17·2%, p-value<0.001). Conclusion: We observed that in patients tested by Public Health Services, SARS-CoV2 viral load increases significantly with age. Previous studies suggest that young children (<12 years) play a limited role in SARS-CoV-2 transmission. Currently, the relation between viral load and infectivity is not yet well understood, and further studies should elucidate whether the lower viral load in children is indeed related to their suggested limited role in SARS-CoV-2 transmission. Moreover, as rapid antigen tests are less sensitive than PCR, these results suggest that SARS-CoV-2 antigen tests could have lower sensitivity in children than in adults.

9 May 2025 in Journal of Infection
Verified
Journal Article
Open access
MHMarieke L.A. de Hoog
Marieke L.A. de Hoog
EWEmma S.E.M. Hauser - van Westrhenen
Emma S.E.M. Hauser - van Westrhenen
AWAngelique M.A.M. Winkel
Angelique M.A.M. Winkel
MJMenno D. de Jong
Menno D. de Jong
VMvan houten ma
van houten ma
PBPatricia C.J.L. Bruijning-Verhagen
Patricia C.J.L. Bruijning-Verhagen
This individual patient data meta-analysis investigates the impact of SARS-CoV-2 infection with or without other respiratory viruses on Acute Respiratory Illness (ARI) occurrence and severity. We pooled individual participant data from 11 prospective COVID-19 community and healthcare cohorts (2020-2024). A subject's first respiratory sample was tested for SARS-CoV-2 and a panel of respiratory viruses. The association of SARS-CoV-2 single versus viral co-infection with ARI occurrence and severity was analyzed using mixed effects regression. The analysis was repeated for Human Rhinovirus (HRV). Of 1606 SARS-CoV-2 positive episodes (1597 subjects), 124 (7.7%) were co-infected with another respiratory virus, the majority with HRV (66.1%). SARS-CoV-2 Co-infection was associated with a lower odds of ARI than SARS-CoV-2 single infection in community cohorts (adjusted (a) OR: 0.39; 95%CI: 0.21-0.71). This association was not observed for ARI severity in healthcare cohorts (aOR: 1.76; 95%CI: 0.67-4.61). Co-infection versus single infection with HRV was associated with higher ARI occurrence and severity in both settings (community: aOR: 1.72 and healthcare: aOR: 6.04). In community settings, SARS-CoV-2 co-infection with another virus, particularly HRV, attenuates ARI compared to SARS-CoV-2 single infection. The low number of detected co-infections with other viruses, such as influenza or RSV, limits generalizability to other combinations of co-infecting viruses.

Verified
Journal Article
Open access
PDF file
MGMarco Goeijenbier
Marco Goeijenbier
SBSjoerd van der Bie
Sjoerd van der Bie
DSDennis Souverein
Dennis Souverein
DBD. Bolluyt
D. Bolluyt
MNM. Nagel
M. Nagel
SLSteven van Lelyveld
Steven van Lelyveld
Background: Mycoplasma pneumoniae (M. pneumoniae) infections can progress to severe respiratory complications, necessitating intensive care treatment. Recent post COVID-19 pandemic surges underscore the need for timely diagnosis, given potential diagnostic method limitations. Methods: A retrospective case series analysis was conducted on M. pneumonia PCR-positive patients admitted to two Dutch secondary hospitals’ ICUs between January 2023 and February 2024. Clinical presentations, treatments, outcomes, and mechanical ventilation data were assessed. Results: Seventeen ICU-admitted patients were identified, with a median age of 44 years, primarily due to hypoxia. Non-invasive ventilation was effective for most, while five required invasive mechanical ventilation. None of the patients required extracorporeal membrane oxygenation. No fatalities occurred. Post-PCR, treatment was adjusted to doxycycline or azithromycin; seven received steroid treatment. Discussion: Increased ICU admissions for M. pneumoniae infection were observed. Diverse clinical and radiological findings emphasize heightened clinical awareness. Early molecular diagnostics and tailored antibiotic regimens are crucial since beta-lactam antibiotics are ineffective. Conclusion: This study highlights the escalating challenge of severe M. pneumoniae infections in ICUs, necessitating a multifaceted approach involving accurate diagnostics, vigilant monitoring, and adaptable treatment strategies for optimal patient outcomes.

2 January 2021 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
MBMatthijs Becker
Matthijs Becker
DSDominic Snijders
Dominic Snijders
CGClaudia W. van Gemeren
Claudia W. van Gemeren
HKHylke Jan Kingma
Hylke Jan Kingma
SLSteven van Lelyveld
Steven van Lelyveld
TGThijs J. Giezen
Thijs J. Giezen

8 November 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
AWAngelique M A M Winkel
Angelique M A M Winkel
EKEva Kozanli
Eva Kozanli
MHMildred E Haverkort
Mildred E Haverkort
SESjoerd M Euser
Sjoerd M Euser
JSJudith G C Sluiter-Post
Judith G C Sluiter-Post
SLSteven van Lelyveld
Steven van Lelyveld
Background: Knowledge of SARS-CoV-2 household transmission dynamics guides infection control and vaccination measures. This household cohort study prospectively assessed the impact of the Omicron BA.2 variant and immunity on household transmission using dense saliva sampling and sequence analysis. Method: Households consisting of a polymerase chain reaction–confirmed index and at least 2 household members were enrolled in March and April 2022 during the Omicron BA.2 wave in the Netherlands. SARS-CoV-2 polymerase chain reaction was performed on 10 consecutive saliva samples. Serum antibodies were measured at baseline and day 42. Household and per-person secondary attack rates (SARs) were calculated to measure transmission. Whole genome sequencing was performed for phylogenetic analysis, followed by sensitivity analysis, to correct for multiple household introductions and index definition. Results were compared with the identical, early-pandemic, preimmunization predecessor study. Results: Sixty-seven households were included, consisting of 241 individuals (median age, 33.0 years; IQR, 12.0–46.0). Maximum household SAR was 59.7% and per-person SAR 41.5%. Pediatric index cases were more likely to transmit. Transmission was negatively affected by household members’ immunity. Phylogenetic analysis showed multiple introductions in 4 households. Sensitivity analysis resulted in a minimal household SAR of 51.0% and per-person SAR of 28.5%. Conclusions: The Omicron BA.2 variant is highly transmissible within households. However, the transmission rate is lower when compared with previous studies with other SARS-CoV-2 variants, highlighting the effect of immunity. Regardless of immune status, children have a crucial role in Omicron household transmission. Intensive sampling and phylogenetic analysis are beneficial for correctly calculating transmission rates, especially during periods of minimal behavioral restrictions.